• 1. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 2. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 3. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 4. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 5. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylmethylamines

Recent Advances in the Study of 863646-17-7 and N,N-diethyl-4-(methylamino)methylaniline in Chemical Biology and Pharmaceutical Research

The compound 863646-17-7 and its derivative, N,N-diethyl-4-(methylamino)methylaniline, have recently garnered significant attention in the field of chemical biology and pharmaceutical research. These molecules are of particular interest due to their potential applications in drug development, particularly as intermediates in the synthesis of bioactive compounds. This research brief aims to provide an overview of the latest findings related to these compounds, focusing on their chemical properties, biological activities, and potential therapeutic applications.

Recent studies have highlighted the role of 863646-17-7 as a key intermediate in the synthesis of novel pharmacophores. Its structural features, including the presence of a reactive amino group, make it a versatile building block for the development of new chemical entities. Researchers have successfully utilized this compound in the synthesis of various heterocyclic compounds, which are known for their diverse biological activities. The derivative, N,N-diethyl-4-(methylamino)methylaniline, has also been investigated for its potential as a modulator of enzymatic activity, particularly in the context of neurodegenerative diseases.

In a recent study published in the Journal of Medicinal Chemistry, researchers explored the pharmacokinetic properties of N,N-diethyl-4-(methylamino)methylaniline. The study demonstrated that this compound exhibits favorable absorption and distribution profiles, making it a promising candidate for further drug development. Additionally, in vitro assays revealed its ability to cross the blood-brain barrier, suggesting potential applications in the treatment of central nervous system disorders. These findings are particularly relevant given the increasing demand for novel therapeutics targeting neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.

Another significant area of research involves the use of 863646-17-7 in the development of fluorescent probes. Due to its unique electronic properties, this compound has been employed as a scaffold for the design of probes capable of detecting reactive oxygen species (ROS) in biological systems. Such probes are invaluable tools for studying oxidative stress, a key factor in numerous pathological conditions, including cancer and inflammatory diseases. Recent advancements in this area have led to the creation of highly sensitive and selective probes, which are now being used in both academic and industrial research settings.

Despite these promising developments, challenges remain in the optimization of these compounds for clinical use. Issues such as metabolic stability, toxicity, and scalability of synthesis need to be addressed in future studies. However, the ongoing research efforts underscore the potential of 863646-17-7 and N,N-diethyl-4-(methylamino)methylaniline as valuable tools in chemical biology and drug discovery. Continued exploration of their properties and applications is expected to yield further insights and innovations in the coming years.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)